US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 23.030
- +1.000+4.54%
Close Nov 6 16:00 ET
- 22.260
- -0.770-3.34%
Post 19:04 ET
1.66BMarket Cap-191916P/E (TTM)
23.170High22.170Low506.01KVolume22.900Open22.030Pre Close11.58MTurnover3.31%Turnover Ratio115.15P/E (Static)72.20MShares28.15052wk High3.80P/B352.16MFloat Cap14.18052wk Low--Dividend TTM15.29MShs Float32.880Historical High--Div YieldTTM4.54%Amplitude5.010Historical Low22.893Avg Price1Lot Size
Kiniksa Pharmaceuticals International Key Stats
EPS
According to the latest financial report of Kiniksa Pharmaceuticals International, the latest earnings per share (TTM) for the company is -0.18. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Kiniksa Pharmaceuticals International's free cash flow? The latest report shows it as -2.24M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Kiniksa Pharmaceuticals International shows that the company's current ratio is 3.24, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Kiniksa Pharmaceuticals International, the quick ratio is 2.59, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Kiniksa Pharmaceuticals International? The latest ROE figure is -2.91%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Kiniksa Pharmaceuticals International, the total asset return on investment (ROA) is -2.31%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Kiniksa Pharmaceuticals International's latest financial report to see how their gross margin is doing - currently at 55.96%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Kiniksa Pharmaceuticals International, the net profit margin is -11.31%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data